123 related articles for article (PubMed ID: 38843043)
1. Piperacillin/tazobactam-induced sudden severe thrombocytopenia in a patient with a pressure ulcer: a case report.
Roh S; Hashimoto K; Kiriishi R; Matsubara K; Isozaki Y; Tanaka H; Kuwata T
J Wound Care; 2024 Jun; 33(Sup6):S25-S30. PubMed ID: 38843043
[TBL] [Abstract][Full Text] [Related]
2. Nephrotoxicity induced by piperacillin–tazobactam in late elderly Japanese patients with nursing and healthcare associated pneumonia.
Karino F; Nishimura N; Ishihara N; Moriyama H; Miura K; Hamaguchi S; Sutani A; Kuraki T; Ikawa K; Morikawa N
Biol Pharm Bull; 2014; 37(12):1971-6. PubMed ID: 25590089
[TBL] [Abstract][Full Text] [Related]
3. [A comparative study of tazobactam/piperacillin and piperacillin in chronic respiratory tract infections].
Oizumi K; Kawahara M; Kawaguchi S; Sigematsu H; Tanaka F; Sano N; Saito A; Hiraga Y; Ohmichi M; Inoue H
Jpn J Antibiot; 1995 Apr; 48(4):482-513. PubMed ID: 7783314
[TBL] [Abstract][Full Text] [Related]
4. Superior effect of tazobactam/piperacillin compared to piperacillin on beta-lactamase-producing Pseudomonas aeruginosa.
Nishida K; Higashitani F; Hyodo A
Chemotherapy; 1997; 43(3):171-8. PubMed ID: 9142457
[TBL] [Abstract][Full Text] [Related]
5. Incidence of acute kidney injury after teicoplanin- or vancomycin- and piperacillin/tazobactam combination therapy: A comparative study using propensity score matching analysis.
Sazanami K; Inose R; Yagi T; Dote S; Horiuchi N; Kobayashi Y; Muraki Y
J Infect Chemother; 2021 Dec; 27(12):1723-1728. PubMed ID: 34446352
[TBL] [Abstract][Full Text] [Related]
6. [Clinical effects of piperacillin and tazobactam/piperacillin on Haemophilus influenzae lower respiratory tract infection in pediatric patients].
Sudo F; Ishiwada N; Hoshino T; Fukasawa C; Inami Y; Hishiki H; Takeda N; Kurosaki T; Kohno Y
Kansenshogaku Zasshi; 2005 Sep; 79(9):637-43. PubMed ID: 16248372
[TBL] [Abstract][Full Text] [Related]
7. [Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field].
Shinagawa N; Yura J; Mashita K; Matsuno S; Rikiyama T; Hirayama T; Tanaka T; Otsuka K; Iwai S; Nakagawa Y
Jpn J Antibiot; 1995 Mar; 48(3):346-67. PubMed ID: 7752449
[TBL] [Abstract][Full Text] [Related]
8. [A comparative study of tazobactam/piperacillin and piperacillin in bacterial pneumonia].
Oizumi K; Ohno T; Kawahara M; Kawaguchi S; Saisho M; Mitutake Y; Saito A; Tomizawa M; Koike T; Takebe K
Jpn J Antibiot; 1995 Apr; 48(4):449-81. PubMed ID: 7783313
[TBL] [Abstract][Full Text] [Related]
9. [Concentration of tazobactam/piperacillin in the cerebrospinal fluid of patients with Haemophilus influenzae type B meningitis].
Fukasawa C; Hoshino T; Kutsuna S; Sawada K; Sato H; Ishiwada N
Kansenshogaku Zasshi; 2013 Sep; 87(5):590-5. PubMed ID: 24195168
[TBL] [Abstract][Full Text] [Related]
10. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the clinical breakpoints of piperacillin-tazobactam against infections caused by Pseudomonas aeruginosa.
Yamagishi Y; Terada M; Ohki E; Miura Y; Umemura T; Mikamo H
J Infect Chemother; 2012 Feb; 18(1):127-9. PubMed ID: 21814800
[TBL] [Abstract][Full Text] [Related]
12. Rapid-Onset Thrombocytopenia Following Piperacillin-Tazobactam Reexposure.
Nguyen VD; Tourigny JF; Roy R; Brouillette D
Pharmacotherapy; 2015 Dec; 35(12):e326-30. PubMed ID: 26684560
[TBL] [Abstract][Full Text] [Related]
13. A puerperal patient with agranulocytosis during tazobactam / piperacillin administration : A case report.
Iwazawa H; Tanaka H; Tatsumichi T; Yamaguchi K; Takahashi K; Suzuki K; Motoki T; Kanenishi K; Kosaka S
J Med Invest; 2021; 68(3.4):368-371. PubMed ID: 34759160
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized comparison study of piperacillin/tazobactam and meropenem for healthcare-associated pneumonia in Japan.
Yamamoto Y; Izumikawa K; Morinaga Y; Nakamura S; Kurihara S; Imamura Y; Miyazaki T; Tsukamoto M; Kakeya H; Yanagihara K; Yasuoka A; Kohno S
J Infect Chemother; 2013 Apr; 19(2):291-8. PubMed ID: 23345050
[TBL] [Abstract][Full Text] [Related]
15. Onset of Hemophagocytic Lymphohistiocytosis during Piperacillin-Tazobactam Therapy in Three Children with Acute Focal Bacterial Nephritis.
Miyabayashi H; Kumaki S; Sato A; Onuma R; Noguchi R; Sato T; Metoki T; Watanabe Y; Tazawa Y; Imaizumi M; Kitaoka S
Tohoku J Exp Med; 2018 May; 245(1):55-59. PubMed ID: 29798969
[TBL] [Abstract][Full Text] [Related]
16. Penetration of piperacillin-tazobactam into human prostate tissue and dosing considerations for prostatitis based on site-specific pharmacokinetics and pharmacodynamics.
Kobayashi I; Ikawa K; Nakamura K; Nishikawa G; Kajikawa K; Yoshizawa T; Watanabe M; Kato Y; Zennami K; Kanao K; Tobiume M; Yamada Y; Mitsui K; Narushima M; Morikawa N; Sumitomo M
J Infect Chemother; 2015 Aug; 21(8):575-80. PubMed ID: 26050020
[TBL] [Abstract][Full Text] [Related]
17. Meropenem versus piperacillin/tazobactam with or without immunoglobulin as second-line therapy for febrile neutropenia in pediatric patients.
Kobayashi R; Hori D; Sano H; Suzuki D; Kishimoto K; Kobayashi K
J Microbiol Immunol Infect; 2018 Aug; 51(4):473-477. PubMed ID: 28690028
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic and clinical evaluation of tazobactam/piperacillin in the pediatric field].
Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
Jpn J Antibiot; 1998 May; 51(5):325-45. PubMed ID: 9693966
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetic, bacteriological and clinical evaluation of tazobactam/piperacillin in pediatrics].
Iwai N; Nakamura H; Miyazu M
Jpn J Antibiot; 1998 May; 51(5):346-61. PubMed ID: 9693967
[TBL] [Abstract][Full Text] [Related]
20. [Antigenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
Takemoto M; Matsuo K; Oguro M; Kouchi Y
J Toxicol Sci; 1994 Oct; 19 Suppl 2():249-62. PubMed ID: 7830290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
